الرئيسية › سرطان المعدة › نيويورك › New York City
التجارب السريرية لـ سرطان المعدة في New York City، NY
31 دراسات لـ سرطان المعدة تبحث عن مشاركين في مواقع داخل وحول New York City (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Hospital, New York
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
جارٍ التسجيلالمرحلة 2/3
- Memorial Sloan Kettering Cancer Center, New York
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
جارٍ التسجيلالمرحلة 3
- Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
جارٍ التسجيلالمرحلة 2/3
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Rockefeller Outpatient Pavilion (53rd Street), New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
جارٍ التسجيلالمرحلة 2
- Research Site, New York
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
جارٍ التسجيلالمرحلة 1
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
جارٍ التسجيلالمرحلة 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
جارٍ التسجيلالمرحلة 3
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
جارٍ التسجيلالمرحلة 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
جارٍ التسجيلالمرحلة 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
جارٍ التسجيلالمرحلة 3
- Research Site, New York
- Research Site, New York
- Research Site, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
جارٍ التسجيلالمرحلة 1
- Icahn School of Medicine at Mount Sinai, New York
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
جارٍ التسجيلالمرحلة 1/2
- Memorial Sloan Kettering Hospital, New York
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
جارٍ التسجيلالمرحلة 1
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
جارٍ التسجيلالمرحلة 3
- Memorial Sloan Kettering Cancer Center - MAIN, New York
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
جارٍ التسجيلالمرحلة 1
- New York Medicine-New York-Presbyterian Hospital, New York
- Montefiore Medical Center - Montefiore Hospital, New York
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
جارٍ التسجيلالمرحلة 2
- Research Site, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
جارٍ التسجيلالمرحلة 1
- Columbia University Irving Medical Center, New York
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
جارٍ التسجيلالمرحلة 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Avutometinib and Defactinib in Diffuse Gastric Cancer
جارٍ التسجيلالمرحلة 2
- Columbia University Irving Medical Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
جارٍ التسجيلدراسة رصدية
- Massive Bio SYNERGY-AI site, New York
Comprehensive Outcomes for After Cancer Health
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- Memorial Sloan Kettering Cancer Center, New York
تجارب سرطان المعدة في مدن أخرى
- Houston, TX42 دراسات
- Boston, MA32 دراسات
- Nashville, TN28 دراسات
- Baldwin Park, CA22 دراسات
- Los Angeles, CA22 دراسات
- Arlington, VA20 دراسات
- Dallas, TX19 دراسات
- San Antonio, TX19 دراسات
- St. Louis, MO18 دراسات
- Grand Rapids, MI18 دراسات
- Washington, DC16 دراسات
- Chicago, IL16 دراسات
دراسات أخرى في New York City
- سرطان الثدي136 دراسات
- سرطان الرئة غير صغير الخلايا121 دراسات
- السرطان (جميع الأنواع)109 دراسات
- سرطان البروستاتا103 دراسات
- السرطان النقيلي93 دراسات
- سرطان القولون والمستقيم78 دراسات
- سرطان المبيض69 دراسات
- سرطان الرئة60 دراسات
- الورم النقوي المتعدد60 دراسات
- سرطان البنكرياس60 دراسات
- سرطان بطانة الرحم52 دراسات
- ابيضاض الدم النقوي الحاد51 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.